UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

The New England journal of medicine, 2011-06, Vol.364 (26), p.2517-2526

2011

Volltextzugriff (PDF)

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

The New England journal of medicine, 2011-06, Vol.364 (26), p.2507-2516

2011

Volltextzugriff (PDF)

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

European journal of cancer (1990), 2010-01, Vol.46 (2), p.270-283

2010

Volltextzugriff (PDF)

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

Journal of immunotherapy, 2009-06, Vol.32 (5), p.498-507

2009

Volltextzugriff (PDF)

Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide

Journal of investigative dermatology, 2009-06, Vol.129 (6), p.1500-1515

2009

Volltextzugriff (PDF)

Combined Inhibition of MAPK and mTOR Signaling Inhibits Growth, Induces Cell Death, and Abrogates Invasive Growth of Melanoma Cells

Journal of investigative dermatology, 2008-08, Vol.128 (8), p.2013-2023

2008

Volltextzugriff (PDF)

Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry

Journal of the American Academy of Dermatology, 2012-01, Vol.66 (1), p.37-45

2012

Volltextzugriff (PDF)

Cathelicidin Anti-Microbial Peptide Expression in Sweat, an Innate Defense System for the Skin

Journal of investigative dermatology, 2002-11, Vol.119 (5), p.1090-1095

2002

Volltextzugriff (PDF)

The Farnesyl Transferase Inhibitor Lonafarnib Inhibits mTOR Signaling and Enforces Sorafenib-Induced Apoptosis in Melanoma Cells

Journal of investigative dermatology, 2011-02, Vol.131 (2), p.468-479

2011

Volltextzugriff (PDF)

Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

International journal of dermatology, 2011-02, Vol.50 (2), p.129-146

2011

Volltextzugriff (PDF)

Generation of Multiple Stable Dermcidin-Derived Antimicrobial Peptides in Sweat of Different Body Sites

Journal of investigative dermatology, 2006-02, Vol.126 (2), p.354-365

2006

Volltextzugriff (PDF)

Extramammary Paget's Disease: Extended Subclinical Growth Detected Using Three‐Dimensional Histology in Routine Paraffin Procedure and Course of the Disease

Dermatologic surgery, 2011-10, Vol.37 (10), p.1417-1426

2011

Volltextzugriff (PDF)

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma

Journal of the American Academy of Dermatology, 2007-10, Vol.57 (4), p.616-621

2007

Volltextzugriff (PDF)

CHEK21100delC and Risk of Malignant Melanoma: Danish and German Studies and Meta-Analysis

Journal of investigative dermatology, 2012-02, Vol.132 (2), p.299-303

2012

Volltextzugriff (PDF)

Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells

Clinical cancer research, 2014-03, Vol.20 (6), p.1601-1609

2014

Volltextzugriff (PDF)

Age and gender are significant independent predictors of survival in primary cutaneous melanoma

Cancer, 2008-04, Vol.112 (8), p.1795-1804

2008

Volltextzugriff (PDF)

Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients

Journal of the American Academy of Dermatology, 2009-05, Vol.60 (5), p.863-868

2009

Volltextzugriff (PDF)

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012

European journal of cancer (1990), 2012-10, Vol.48 (15), p.2375-2390

2012

Volltextzugriff (PDF)

Truncation of Activated Leukocyte Cell Adhesion Molecule: A Gateway to Melanoma Metastasis

Journal of investigative dermatology, 2004-05, Vol.122 (5), p.1293-1301

2004

Volltextzugriff (PDF)

Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma

Cancer, 2011-04, Vol.117 (8), p.1697-1703

2011

Volltextzugriff (PDF)

High Response Rate After Intratumoral Treatment With Interleukin-2: Results From a Phase 2 Study in 51 Patients With Metastasized Melanoma

Cancer, 2010-09, Vol.116 (17), p.4139-4146

2010

Volltextzugriff (PDF)

Risk Factors for Developing Cutaneous Melanoma and Criteria for Identifying Persons at Risk: Multicenter Case-Control Study of the Central Malignant Melanoma Registry of the German Dermatological Society

Journal of investigative dermatology, 1994-05, Vol.102 (5), p.695-699

1994

Volltextzugriff (PDF)

Extreme UV exposure of professional cyclists

Dermatology (Basel), 2000-01, Vol.201 (1), p.44-45

2000

Volltextzugriff (PDF)

A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma

Clinical cancer research, 2011-12, Vol.17 (24), p.7732-7742

2011

Volltextzugriff (PDF)

Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis

Annals of oncology, 2008-06, Vol.19 (6), p.1195-1201

2008

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Aktive Filter

KollektioneBooks on EBSCOhost

Zeitschrift / SerieInternational Journal Of Cancer

Zeitschrift / SerieJournal Of Clinical Oncology

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(101)

Sprache

Englisch
(101)

Erscheinungsjahr

n.n

Thema

Medical Sciences
(98)
Humans
(90)
Dermatology
(88)
Life Sciences & Biomedicine
(86)
Science & Technology
(86)
Tumors Of The Skin And Soft Tissue. Premalignant Lesions
(67)
Female
(64)
Male
(62)
Middle Aged
(48)
Adult
(44)
Aged
(43)
Skin Neoplasms - Pathology
(36)
Oncology
(30)
Melanoma - Pathology
(29)
Melanoma
(25)
Prognosis
(21)
Melanoma - Mortality
(19)
Aged, 80 And Over
(18)
Tumors
(18)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide

Combined Inhibition of MAPK and mTOR Signaling Inhibits Growth, Induces Cell Death, and Abrogates Invasive Growth of Melanoma Cells

Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry

Cathelicidin Anti-Microbial Peptide Expression in Sweat, an Innate Defense System for the Skin

The Farnesyl Transferase Inhibitor Lonafarnib Inhibits mTOR Signaling and Enforces Sorafenib-Induced Apoptosis in Melanoma Cells

Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

Generation of Multiple Stable Dermcidin-Derived Antimicrobial Peptides in Sweat of Different Body Sites

Extramammary Paget's Disease: Extended Subclinical Growth Detected Using Three‐Dimensional Histology in Routine Paraffin Procedure and Course of the Disease

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma

CHEK21100delC and Risk of Malignant Melanoma: Danish and German Studies and Meta-Analysis

Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells

Age and gender are significant independent predictors of survival in primary cutaneous melanoma

Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012

Truncation of Activated Leukocyte Cell Adhesion Molecule: A Gateway to Melanoma Metastasis

Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma

High Response Rate After Intratumoral Treatment With Interleukin-2: Results From a Phase 2 Study in 51 Patients With Metastasized Melanoma

Risk Factors for Developing Cutaneous Melanoma and Criteria for Identifying Persons at Risk: Multicenter Case-Control Study of the Central Malignant Melanoma Registry of the German Dermatological Society

Extreme UV exposure of professional cyclists

A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma

Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis

Aktive Filter

Suchergebnisse filtern